Literature DB >> 8473287

Domain structure and domain-domain interactions in human coagulation factor IX.

A Vysotchin1, L V Medved, K C Ingham.   

Abstract

Coagulation factor IX has the modular composition Gla-(EGF)2-SP, where Gla, EGF, and SP represent the gamma-carboxy-Glu-rich, epidermal growth factor-like, and serine protease modules, respectively. The protein melts in two distinct temperature regions. The SP module melts at lower temperature between 42 and 55 degrees C, depending on the pH, with irreversible loss of esterolytic activity. The endotherm corresponding to this transition is readily described by a two-state transition indicating the melting of a single cooperative unit. A thrombin-generated 12-kDa fragment representing the COOH-terminal half of the SP module and a 45-kDa fragment containing the NH2-terminal half of the SP module and the rest of the molecule can be separated by exclusion chromatography in 3 M urea and recombined in its absence. Both fragments retain a compact structure as evidenced by melting transitions near 60 degrees C at neutral pH. This indicates that the SP module contains two independently folded domains that strongly interact with each other and seem to merge into one cooperative unit in the intact protein. At low pH at high temperature a second peak appears which is also observed in a 19-kDa fragment containing the EGF modules. Thermodynamic analysis of this second peak showed that the two EGF modules are independently folded and provided evidence for a weak interaction between them. Fluorescence and CD measurements indicated that the secondary structure of the isolated 6-kDa Gla fragment is substantially increased in the presence of Ca2+. The Ca2+-loaded Gla fragment undergoes a sigmoidal unfolding transition as revealed by fluorescence and CD measurements. This same transition in a 25-kDa Gla-(EGF)2 fragment was stabilized by more than 10 degrees C, indicating a strong interaction between the Ca(2+)-loaded Gla and EGF domains. Thus, factor IX consists of five independently folded interacting domains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473287

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Identification of an ordered compact structure within the recombinant bovine fibrinogen alphaC-domain fragment by NMR.

Authors:  Robert A Burton; Galina Tsurupa; Leonid Medved; Nico Tjandra
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

2.  Determinants of the factor IX mutational spectrum in haemophilia B: an analysis of missense mutations using a multi-domain molecular model of the activated protein.

Authors:  A I Wacey; M Krawczak; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

3.  gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.

Authors:  S Gillis; B C Furie; B Furie; H Patel; M C Huberty; M Switzer; W B Foster; H A Scoble; M D Bond
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

4.  Thermal stability of the three domains of streptokinase studied by circular dichroism and nuclear magnetic resonance.

Authors:  F Conejero-Lara; J Parrado; A I Azuaga; R A Smith; C P Ponting; C M Dobson
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

5.  Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.

Authors:  P O Freskgård; O H Olsen; E Persson
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

6.  First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.

Authors:  D Zhong; K J Smith; J J Birktoft; S P Bajaj
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Homology modeling and molecular dynamics simulation of human prothrombin fragment 1.

Authors:  L Li; T Darden; C Foley; R Hiskey; L Pedersen
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

Review 8.  The Molecular Basis of FIX Deficiency in Hemophilia B.

Authors:  Guomin Shen; Meng Gao; Qing Cao; Weikai Li
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.